|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM258270969 |
003 |
DE-627 |
005 |
20231224184636.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2016 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2016.03.007
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0860.xml
|
035 |
|
|
|a (DE-627)NLM258270969
|
035 |
|
|
|a (NLM)26960949
|
035 |
|
|
|a (PII)S1521-6616(16)30033-X
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Kajdácsi, Erika
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Atrial natriuretic peptide as a novel biomarker of hereditary angioedema
|
264 |
|
1 |
|c 2016
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 31.08.2016
|
500 |
|
|
|a Date Revised 19.04.2016
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
650 |
|
4 |
|a Letter
|
650 |
|
4 |
|a Atrial natriuretic peptide
|
650 |
|
4 |
|a Attack
|
650 |
|
4 |
|a Biomarker
|
650 |
|
4 |
|a C1 inhibitor deficiency
|
650 |
|
4 |
|a Clinical study
|
650 |
|
4 |
|a Hereditary angioedema
|
650 |
|
7 |
|a Biomarkers
|2 NLM
|
650 |
|
7 |
|a Atrial Natriuretic Factor
|2 NLM
|
650 |
|
7 |
|a 85637-73-6
|2 NLM
|
700 |
1 |
|
|a Varga, Lilian
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Prohászka, Zoltán
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Farkas, Henriette
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cervenak, László
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 165(2016) vom: 05. Apr., Seite 45-6
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:165
|g year:2016
|g day:05
|g month:04
|g pages:45-6
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2016.03.007
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 165
|j 2016
|b 05
|c 04
|h 45-6
|